Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
AI Proteins Announces the Formation of a Scientific Advisory Board Made up of Experts in Biotech and FDA Drug Approval
AI Proteins, a growing biotechnology company that utilizes computational de novo protein design to create […]
Nexus Pharmaceuticals Announces Appointment of New Board Members
Nexus Pharmaceuticals, a privately-owned U.S.-based healthcare company, has announced the appointment of Edgar Lee and […]
Abivax Appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
Abivax, a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune […]
SamaCare Welcomes Komodo Health CEO Arif Nathoo to Board of Directors
SamaCare, a prior authorization platform for physician-administered medications, is excited to announce the addition of […]
Nanoscope Therapeutics Appoints Industry Veteran Vicente Anido Jr., Ph.D., as a Strategic Advisor
Nanoscope Therapeutics, a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced […]
Poseida Therapeutics Appoints Five New Members to Its Gene Therapy Scientific Advisory Board
Poseida Therapeutics, a clinical-stage cell and gene therapy company advancing a new class of treatments […]
BioSenic appoints Yves Sagot as Independent Director
BioSenic, the clinical stage company specializing in serious autoimmune/inflammatory diseases and cell repair, today announces […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more